PlusPlus Lifesciences, a healthcare firm, stated it had acquired a patent from the Patent Office of the Government of India for its three-stage Multi-Micronutrient (MMN) complement referred to as Trimacare.
With this, the corporate has introduced plans to introduce and distribute this product nationwide.
“Trimacare is a supplement based on the MMN model of medication. This model combines traditional nutrients such as Iron, Folic Acid, and Calcium with other essential vitamins and minerals like Iodine, Zinc, Omega-3, fatty acids, Vitamins A, B, and D, among others, that are necessary for the health of pregnant women throughout all trimesters and the child’s prenatal and long-term health,” the corporate stated.
Raj Kamal Agarwal, President, PlusPlus Lifesciences in a press release stated, “Trimacare is a transformative formulation in the field of medicine. It is based on the Multi-Micronutrient model of medication and includes more than 20 nutrients and a unique formulation for each trimester.”
“It is prepared with plant-based sources to cater to evolving lifestyles and eating habits. We look forward to launching Trimacare and making it available nationwide and accessible to every expectant mother, ensuring they achieve optimal prenatal health,” he added.
